journal article·2020-01-01Open access

Dexmedetomidine protects PC12 cells from oxidative damage through regulation of miR-199a/HIF-1α

Ling Wu, Yalin Xi, Qinglong Kong

Abstract

Background Although dexmedetomidine (Dex) has a significant neuroprotective effect in various nerve-damage models, the exact mechanism of which Dex protects cells from oxidative damage is not fully clear. This article recommended the protective effect of Dex on oxidative damage in PC12 cells.Methods The PC12 cells were incubated by hydrogen peroxide (H2O2) for 24 h and pre-treated by Dex for 30 min. Cell viability, apoptosis, HIF-1α expression and ROS level were detected by CCK-8, apoptosis assay, Western blot and ROS assay, respectively. The miR-199a expression was tested by qRT-PCR. Targeting relationship between miR-199a and HIF-1α was performed by dual luciferase activity assay. The activation of PI3K/AKT/mTOR and Wnt/β-catenin pathways was tested by western blot.Results Dex attenuated H2O2-induced oxidative damage, including the decline of cell viability, the raise of apoptosis and the generation of ROS in PC12 cells by down-regulating miR-199a expression. Moreover, Dex up-regulated HIF-1α expression via decreasing miR-199a level in PC12 cells and miR-199a targeted the 3′-UTR of HIF-1α. In addition, Dex activated PI3K/AKT/mTOR and Wnt/β-catenin pathways by declining miR-199a level.Conclusions This article illustrated the protective effect of Dex on oxidative damage in PC12 cells. Furthermore, Dex prevented PC12 cells from oxidative injury through the regulation of miR-199a/HIF-1α.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Anesthesia and Neurotoxicity Research · Neurogenesis and neuroplasticity mechanisms · Cancer, Stress, Anesthesia, and Immune Response

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Clinical Pharmacy, Dalian Central Hospital

Department of Thoracic Surgery, Dalian Central Hospital

References (45)

Show source-provided references
1. 10.3233/JAD-13273810.3233/JAD-132738 ↗
2. 10.1124/jpet.116.23750310.1124/jpet.116.237503 ↗
3. 10.1155/2015/53037110.1155/2015/530371 ↗
4. 10.1007/s12013-013-9659-810.1007/s12013-013-9659-8 ↗
5. 10.1007/s10753-014-9906-110.1007/s10753-014-9906-1 ↗
6. 10.1016/j.neulet.2019.13430910.1016/j.neulet.2019.134309 ↗
7. Wang Y, Jia A, Ma W. Dexmedetomidine attenuates the toxicity of betaamyloid on neurons and astrocytes by increasing BDNF production under the regulation of HDAC2 and HDAC5. Mol Med Rep. 2019;19(1):533–540.
8. 10.1007/978-3-319-22671-2_610.1007/978-3-319-22671-2_6 ↗
9. 10.1016/j.pneurobio.2019.10166410.1016/j.pneurobio.2019.101664 ↗
10. Yoram Barak PG. Do social isolation and loneliness kill people with Alzheimer’s disease? OBM Geriatr. 2018;2(4).
11. Liu W, Li L. MicroRNA expression profiling screen miR-3557/324-targeted CaMK/mTOR in the rat striatum of Parkinson’s disease in regular aerobic exercise. BioMed Res Int. 2019;2019:7654798.
12. 10.1016/j.lfs.2019.04.00410.1016/j.lfs.2019.04.004 ↗
13. 10.1016/j.neurobiolaging.2018.05.03210.1016/j.neurobiolaging.2018.05.032 ↗
14. 10.18632/oncotarget.335210.18632/oncotarget.3352 ↗
15. 10.1073/pnas.131724211110.1073/pnas.1317242111 ↗
16. 10.1378/chest.11-274610.1378/chest.11-2746 ↗
17. 10.18632/oncotarget.174710.18632/oncotarget.1747 ↗
18. 10.1016/j.neuropharm.2013.07.04010.1016/j.neuropharm.2013.07.040 ↗
19. 10.1089/rej.2012.138410.1089/rej.2012.1384 ↗
20. 10.1016/j.neulet.2014.05.02110.1016/j.neulet.2014.05.021 ↗
21. 10.3390/ijms1601019310.3390/ijms16010193 ↗
22. 10.1080/01616412.2017.128119710.1080/01616412.2017.1281197 ↗
23. 10.1097/00000542-200202000-0003410.1097/00000542-200202000-00034 ↗
24. Chen Y, Zhao Z, Code WE, et al. A correlation between dexmedetomidine-induced biphasic increases in free cytosolic calcium concentration and energy metabolism in astrocytes. Anesth Analg. 2000;91(2):353–357.
25. 10.1016/j.surneu.2007.08.02010.1016/j.surneu.2007.08.020 ↗
26. 10.1111/aas.1235610.1111/aas.12356 ↗
27. 10.3109/02699052.2014.88876510.3109/02699052.2014.888765 ↗
28. 10.1016/j.cellsig.2017.05.00110.1016/j.cellsig.2017.05.001 ↗
29. 10.1161/CIRCRESAHA.108.19310210.1161/CIRCRESAHA.108.193102 ↗
30. 10.1371/journal.pone.000762910.1371/journal.pone.0007629 ↗
31. 10.1128/MCB.01242-1010.1128/MCB.01242-10 ↗
32. 10.1172/JCI4298010.1172/JCI42980 ↗
33. 10.3389/fonc.2019.0065310.3389/fonc.2019.00653 ↗
34. Zhang H, Zhu S, Zhang C, et al. miR-199a-5p inhibits the proliferation of rat airway smooth muscle cells and the expression of hypoxia inducible factor 1 alpha under hypoxia conditions. Xi Bao yu Fen zi Mian yi Xue za Zhi [Chin J Cell Mol Immunol]. 2015;31(9):1183–1188.
35. 10.18632/oncotarget.1446110.18632/oncotarget.14461 ↗
36. 10.1289/ehp.130754510.1289/ehp.1307545 ↗
37. Wang H, Wang Z, Tang Q. Reduced expression of microRNA-199a-3p is associated with vascular endothelial cell injury induced by type 2 diabetes mellitus. Exp Ther Med. 2018;16(4):3639–3645.
38. 10.1016/j.brainresbull.2019.06.00410.1016/j.brainresbull.2019.06.004 ↗
39. 10.4103/1673-5374.23871710.4103/1673-5374.238717 ↗
40. 10.1016/j.neulet.2007.12.03410.1016/j.neulet.2007.12.034 ↗
41. 10.1016/j.jchemneu.2019.04.00310.1016/j.jchemneu.2019.04.003 ↗
42. 10.1007/s12031-018-1219-710.1007/s12031-018-1219-7 ↗
43. 10.1080/21691401.2019.163680510.1080/21691401.2019.1636805 ↗
44. 10.1016/j.bbrc.2015.02.13710.1016/j.bbrc.2015.02.137 ↗
45. 10.1038/s41598-018-32189-510.1038/s41598-018-32189-5 ↗